Anton PR, Arnspang PS, Johannesdottir SSA, Rosenkrantz HLL, S?Ren F, David G. Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma. Jama Internal Medicine. 2018.
Ernestina, Marianna, De, Francesco, Rosamaria, Lappano, Maria, Francesca, Santolla, Stefania. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs). Breast Cancer Research. 2013.
Faraj B, Camp V, Murray D, Kutner M, Heam J, Nixon D. Plasma L-Dopain the Diagnosisof MalignantMelanoma. 2020.
Gaustad JV, Simonsen TG, Andersen LMK, Rofstad EK. Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts. Journal of Translational Medicine. 2017;15:241.
Giuseppina, Comito, and, Maura, Calvani, and, Elisa, Giannoni, and, Francesca. HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radical Biology & Medicine. 2011.
Guan G, Zhang Y, Lu Y, Liu L, Shi D, Wen Y, Yang L, Ma Q, Liu T, Zhu X. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells. Cancer Letters. 2015;357:254-64.
Hu J, Yang D, Wei C, Li C, Wang Y, Zeng Y, Hui W. Whole Blood Transcriptome Sequencing Reveals Gene Expression Differences between Dapulian and Landrace Piglets. BioMed Research International. 2016;2016:1-10.
Johan B, Van dKAJ, Jasper L, Rademakers SE, Ham KJ. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. Bmc Cancer. 2011;11:1-10.
Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nature Methods. 2015;12:357-60.
Kim TH, Hur EG, Kang SJ, Kim JA, Thapa D, Lee YM, Ku SK, Jung Y, Kwak MK. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. Cancer Research. 2011;71:2260.
Loftus SK, Baxter LL, Cronin JC, Fufa TD, Pavan WJ. Hypoxia-induced HIF1 <i>α</i> targets in melanocytes reveal a molecular profile associated with poor melanoma prognosis. Pigment Cell & Melanoma Research. 2017.
Meneghetti A, Peserico G, Pelizzaro F, Pozzan C, Iurilli V, Vezzaro R, Cardin R, Piciocchi M, Paccagnella D, Farinati F. Prognostic role of vascular endothelial growth factor and hypoxia inducible factor in HCC patients after conventional and DEB-mediated chemoembolization. Digestive & Liver Disease. 2017;49:e35.
Nakayama K, Kanzaki A, Hata K, Katabuchi H, Takebayashi Y. Hypoxia-inducible factor 1α (HIF-1α) gene expression in human ovarian carcinoma. Cancer Letters. 2002;176:215-23.
Nueda MJ, Martorell-Marugan J, Martí C, Tarazona S, Conesa A. Identification and visualization of differential isoform expression in RNA-seq time series. Bioinformatics. 2018;34:524-6.
Pan Q, Shai O Fau - Lee LJ, Lee Lj Fau - Frey BJ, Frey Bj Fau - Blencowe BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.
Sasabe E, Tatemoto Y, Li D, Yamamoto T, Osaki T. Mechanism of HIF‐1α‐dependent suppression of hypoxia‐induced apoptosis in squamous cell carcinoma cells. Cancer Science. 2005;96.
Spence VA, Beck JS. Transcutaneous measurement of PO<sub>2</sub> and PCO<sub>2</sub> in the dermis at the site of the tuberculin reaction in healthy human subjects. Journal of Pathology. 2005;155:289-93.
Xinghua, Yang, Shaorong, Lei, Jianhong, Long, Xiaojin, Liu, Qizhen, Wu. MicroRNA-199a-5p inhibits tumor proliferation in melanoma by mediating HIF-1α. Molecular Medicine Reports. 2016.
Zhigalova N, Artemov A, Mazur A, Prokhortchouk E. Transcriptome sequencing revealed differences in the response of renal cancer cells to hypoxia and CoCl2 treatment. F1000research. 2015;4:1518.